The prevention of muscle pains associated with the use of suxamethonium.
D000328:Adult; D001463:Barbiturates / Q000009:adverse effects; D001999:Bronchoscopy / Q000009:adverse effects; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins; D009132:Muscles / Q000627:therapeutic use*; D009135:Muscular Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D009388:Neostigmine / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D011183:Postoperative Complications; D011188:Potassium / Q000097:blood; D013390:Succinylcholine / Q000009:adverse effects*; D013874:Thiopental / Q000009:adverse effects; D014403:Tubocurarine / Q000627:therapeutic use
D001463:Barbiturates; D009124:Muscle Proteins; D009388:Neostigmine; D013390:Succinylcholine; D013874:Thiopental; D011188:Potassium; D014403:Tubocurarine